ArticleFrontiers in oncology2026

Frailty, nutritional status, and inflammation as determinants of chemotherapy delivery and outcomes in pancreatic cancer patients receiving gemcitabine plus nab-paclitaxel.

Ho Seung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.